查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1763907

體外受精市場－全球產業規模、佔有率、趨勢、機會和預測，按技術、產品、卵子捐贈者、不孕症類型、應用、地區和競爭細分，2020-2030 年預測

In-Vitro Fertilization Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Technique, By Product, By Egg Donor, By Infertility, By Application By Region & Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024 年全球體外受精市場規模為 284.1 億美元，預計到 2030 年將達到 408.7 億美元，預測期內的複合年成長率為 6.25%。市場成長的驅動力包括不孕症上升、輔助生殖技術進步、生育年齡延遲的趨勢。體外受精 (IVF) 是一種被廣泛採用的輔助生殖技術 (ART)，它涉及在體外使卵子與精子受精，然後將胚胎移植到子宮。 IVF 已幫助全球數百萬人克服不孕不育。人口老化、生活方式改變和環境壓力等因素導致不孕症上升，從而推動了對 ART 解決方案的需求。此外，IVF 程序的進步（例如改進的胚胎培養系統和個人化方案）提高了成功率。政府的支持性舉措、醫療保健服務的擴大以及公眾意識的增強也使 IVF 更容易獲得，尤其是在新興經濟體中，這些國家不斷壯大的中產階級和保險覆蓋率進一步推動了市場應用。

市場概覽
預測期 2026-2030
2024年市場規模 284.1億美元
2030年市場規模 408.7億美元
2025-2030 年複合年成長率 6.25%
成長最快的領域 醫院
最大的市場 北美洲

關鍵市場促進因素

全球不孕不育率上升

主要市場挑戰

治療費用高且難以取得

主要市場趨勢

生育力保存的接受度不斷提高

目錄

第1章：服務概述

  • 市場定義
  • 市場範圍
    • 覆蓋市場
    • 考慮學習的年限
    • 主要市場區隔

第2章：研究方法

第3章：執行摘要

第4章：顧客之聲

第5章：全球體外受精市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 依技術分類（ICSI IVF vs. 非 ICSI/傳統 IVF）
    • 依產品（IVF培養基、ICSI機器、IVF孵化器、低溫系統等）
    • 依卵子捐贈者分類（冷凍非捐贈者、新鮮非捐贈者、冷凍捐贈者、新鮮捐贈者）
    • 按不孕症（男性 vs. 女性）
    • 按應用（生育診所、醫院、其他）
    • 按地區
    • 按公司分類（2024）
  • 產品圖

第6章：北美體外受精市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 北美：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲體外受精市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 歐洲：國家分析
    • 法國
    • 德國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太體外受精市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：南美洲體外受精市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第10章：中東與非洲體外受精市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • MEA：國家分析
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第 11 章：市場動態

  • 驅動程式
  • 挑戰

第 12 章：市場趨勢與發展

  • 近期發展
  • 併購
  • 產品發布

第 13 章：全球體外受精市場：SWOT 分析

第 14 章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 顧客的力量
  • 替代產品的威脅

第 15 章：競爭格局

  • The Fertility Center of Las Vegas
  • Overlake Reproductive Health
  • Gennet City Fertility
  • Zita West Clinic
  • Fertility Plus Clinic
  • Nova IVF Centre and Fertility Clinic
  • Bloom IVF Centre
  • Progenesis Fertility Center
  • Medicana IVF Center
  • Medical Park Hospitals
  • ART Fertility Clinics

第 16 章：策略建議

第17章調查會社について,免責事項

簡介目錄
Product Code: 15131

The Global In-Vitro Fertilization Market was valued at USD 28.41 billion in 2024 and is projected to reach USD 40.87 billion by 2030, growing at a CAGR of 6.25% during the forecast period. Market growth is driven by rising infertility rates, technological advancements in assisted reproduction, and the increasing trend of delayed parenthood. In-vitro fertilization (IVF), a widely adopted assisted reproductive technology (ART), involves fertilizing an egg with sperm outside the body and transferring the embryo to the uterus. IVF has helped millions worldwide overcome infertility. Factors such as aging populations, lifestyle changes, and environmental stressors are contributing to rising infertility, pushing demand for ART solutions. Furthermore, advancements in IVF procedures-like improved embryo culture systems and personalized protocols-have increased success rates. Supportive government initiatives, expanded healthcare access, and growing public awareness are also making IVF more accessible, particularly in emerging economies, where a growing middle class and insurance coverage are further driving market adoption.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 28.41 Billion
Market Size 2030USD 40.87 Billion
CAGR 2025-20306.25%
Fastest Growing SegmentHospital
Largest MarketNorth America

Key Market Drivers

Rising Infertility Rates Globally

The increasing global prevalence of infertility is a primary driver of the IVF market. According to the World Health Organization (WHO), one in six individuals faces infertility during their lifetime. Contributing factors include delayed parenthood, lifestyle habits, stress, obesity, and environmental pollutants. Fertility declines significantly in women after age 35, while male infertility is also rising due to reduced sperm quality. Governments and healthcare systems are acknowledging this challenge by supporting access to fertility treatments. In Europe, several countries offer full or partial reimbursement for IVF, while awareness initiatives by NGOs and health agencies are breaking social stigmas and encouraging treatment. Additionally, improved healthcare infrastructure and insurance access in developing nations are further enabling IVF adoption among a broader population base.

Key Market Challenges

High Cost of Treatment and Limited Accessibility

Despite growing demand, the high cost of IVF treatment remains a significant barrier, especially in low- and middle-income countries. IVF procedures often require substantial financial investment, with multiple cycles sometimes needed to achieve success. In many regions, fertility treatments are not fully covered by insurance, limiting access to those with financial means. For example, in the United States, IVF is frequently excluded from standard insurance plans, making it less accessible. In contrast, countries like Israel and certain parts of Europe provide public funding, resulting in higher uptake rates. The lack of universal coverage and inconsistent reimbursement structures continue to restrict broader adoption of IVF services.

Key Market Trends

Growing Acceptance of Fertility Preservation

Fertility preservation is emerging as a notable trend in the IVF market. Procedures such as egg, sperm, and embryo freezing are gaining popularity among individuals postponing parenthood for personal, career, or medical reasons. This trend is supported by healthcare providers and employers alike, with some companies now including fertility preservation as part of employee benefits. Additionally, fertility preservation is increasingly integrated into cancer care, with guidelines from medical bodies like ASCO recommending early discussions on fertility options before treatment. As public awareness and social acceptance of assisted reproduction continue to rise, the appeal of fertility preservation is expanding the IVF user base beyond traditional infertility patients, indicating strong long-term growth potential.

Key Market Players

  • The Fertility Center of Las Vegas
  • Overlake Reproductive Health
  • Gennet City Fertility
  • Zita West Clinic
  • Fertility Plus Clinic
  • Nova IVF Centre and Fertility Clinic
  • Bloom IVF Centre
  • Progenesis Fertility Center
  • Medicana IVF Center
  • Medical Park Hospitals
  • ART Fertility Clinics

Report Scope:

In this report, the Global In-Vitro Fertilization Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

In-Vitro Fertilization Market, By Technique:

  • ICSI IVF
  • Non-ICSI/ Traditional IVF

In-Vitro Fertilization Market, By Product:

  • IVF Culture Media
  • ICSI Machine
  • IVF Incubators
  • Cryo-System
  • Others

In-Vitro Fertilization Market, By Egg Donor:

  • Frozen non-donor
  • Fresh non-donor
  • Frozen Donor
  • Fresh Donor

In-Vitro Fertilization Market, By Infertility:

  • Male
  • Female

In-Vitro Fertilization Market, By Application:

  • Fertility Clinics
  • Hospitals
  • Others

In-Vitro Fertilization Market, By Region:

  • North America
    • United States
    • Mexico
    • Canada
  • Europe
    • France
    • Germany
    • United Kingdom
    • Italy
    • Spain
  • Asia-Pacific
    • China
    • India
    • South Korea
    • Japan
    • Australia
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East and Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global In-Vitro Fertilization Market.

Available Customizations:

Global In-Vitro Fertilization Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Service Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validations
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global In-Vitro Fertilization Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Technique (ICSI IVF v/s Non-ICSI/ Traditional IVF)
    • 5.2.2. By Product (IVF Culture Media, ICSI Machine, IVF Incubators, Cryo-System, Others)
    • 5.2.3. By Egg Donor (Frozen Non-donor, Fresh Non-donor, Frozen Donor, Fresh Donor)
    • 5.2.4. By Infertility (Male v/s Female)
    • 5.2.5. By Application (Fertility Clinics, Hospitals, Others)
    • 5.2.6. By Region
    • 5.2.7. By Company (2024)
  • 5.3. Product Map

6. North America In-Vitro Fertilization Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Technique
    • 6.2.2. By Product
    • 6.2.3. By Egg Donor
    • 6.2.4. By Infertility
    • 6.2.5. By Application
    • 6.2.6. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States In-Vitro Fertilization Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Technique
        • 6.3.1.2.2. By Product
        • 6.3.1.2.3. By Egg Donor
        • 6.3.1.2.4. By Infertility
        • 6.3.1.2.5. By Application
    • 6.3.2. Canada In-Vitro Fertilization Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Technique
        • 6.3.2.2.2. By Product
        • 6.3.2.2.3. By Egg Donor
        • 6.3.2.2.4. By Infertility
        • 6.3.2.2.5. By Application
    • 6.3.3. Mexico In-Vitro Fertilization Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Technique
        • 6.3.3.2.2. By Product
        • 6.3.3.2.3. By Egg Donor
        • 6.3.3.2.4. By Infertility
        • 6.3.3.2.5. By Application

7. Europe In-Vitro Fertilization Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Technique
    • 7.2.2. By Product
    • 7.2.3. By Egg Donor
    • 7.2.4. By Infertility
    • 7.2.5. By Application
    • 7.2.6. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France In-Vitro Fertilization Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Technique
        • 7.3.1.2.2. By Product
        • 7.3.1.2.3. By Egg Donor
        • 7.3.1.2.4. By Infertility
        • 7.3.1.2.5. By Application
    • 7.3.2. Germany In-Vitro Fertilization Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Technique
        • 7.3.2.2.2. By Product
        • 7.3.2.2.3. By Egg Donor
        • 7.3.2.2.4. By Infertility
        • 7.3.2.2.5. By Application
    • 7.3.3. United Kingdom In-Vitro Fertilization Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Technique
        • 7.3.3.2.2. By Product
        • 7.3.3.2.3. By Egg Donor
        • 7.3.3.2.4. By Infertility
        • 7.3.3.2.5. By Application
    • 7.3.4. Italy In-Vitro Fertilization Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Technique
        • 7.3.4.2.2. By Product
        • 7.3.4.2.3. By Egg Donor
        • 7.3.4.2.4. By Infertility
        • 7.3.4.2.5. By Application
    • 7.3.5. Spain In-Vitro Fertilization Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Technique
        • 7.3.5.2.2. By Product
        • 7.3.5.2.3. By Egg Donor
        • 7.3.5.2.4. By Infertility
        • 7.3.5.2.5. By Application

8. Asia-Pacific In-Vitro Fertilization Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Technique
    • 8.2.2. By Product
    • 8.2.3. By Egg Donor
    • 8.2.4. By Infertility
    • 8.2.5. By Application
    • 8.2.6. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China In-Vitro Fertilization Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Technique
        • 8.3.1.2.2. By Product
        • 8.3.1.2.3. By Egg Donor
        • 8.3.1.2.4. By Infertility
        • 8.3.1.2.5. By Application
    • 8.3.2. India In-Vitro Fertilization Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Technique
        • 8.3.2.2.2. By Product
        • 8.3.2.2.3. By Egg Donor
        • 8.3.2.2.4. By Infertility
        • 8.3.2.2.5. By Application
    • 8.3.3. Japan In-Vitro Fertilization Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Technique
        • 8.3.3.2.2. By Product
        • 8.3.3.2.3. By Egg Donor
        • 8.3.3.2.4. By Infertility
        • 8.3.3.2.5. By Application
    • 8.3.4. South Korea In-Vitro Fertilization Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Technique
        • 8.3.4.2.2. By Product
        • 8.3.4.2.3. By Egg Donor
        • 8.3.4.2.4. By Infertility
        • 8.3.4.2.5. By Application
    • 8.3.5. Australia In-Vitro Fertilization Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Technique
        • 8.3.5.2.2. By Product
        • 8.3.5.2.3. By Egg Donor
        • 8.3.5.2.4. By Infertility
        • 8.3.5.2.5. By Application

9. South America In-Vitro Fertilization Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Technique
    • 9.2.2. By Product
    • 9.2.3. By Egg Donor
    • 9.2.4. By Infertility
    • 9.2.5. By Application
    • 9.2.6. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil In-Vitro Fertilization Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Technique
        • 9.3.1.2.2. By Product
        • 9.3.1.2.3. By Egg Donor
        • 9.3.1.2.4. By Infertility
        • 9.3.1.2.5. By Application
    • 9.3.2. Argentina In-Vitro Fertilization Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Technique
        • 9.3.2.2.2. By Product
        • 9.3.2.2.3. By Egg Donor
        • 9.3.2.2.4. By Infertility
        • 9.3.2.2.5. By Application
    • 9.3.3. Colombia In-Vitro Fertilization Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Technique
        • 9.3.3.2.2. By Product
        • 9.3.3.2.3. By Egg Donor
        • 9.3.3.2.4. By Infertility
        • 9.3.3.2.5. By Application

10. Middle East and Africa In-Vitro Fertilization Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Technique
    • 10.2.2. By Product
    • 10.2.3. By Egg Donor
    • 10.2.4. By Infertility
    • 10.2.5. By Application
    • 10.2.6. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa In-Vitro Fertilization Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Technique
        • 10.3.1.2.2. By Product
        • 10.3.1.2.3. By Egg Donor
        • 10.3.1.2.4. By Infertility
        • 10.3.1.2.5. By Application
    • 10.3.2. Saudi Arabia In-Vitro Fertilization Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Technique
        • 10.3.2.2.2. By Product
        • 10.3.2.2.3. By Egg Donor
        • 10.3.2.2.4. By Infertility
        • 10.3.2.2.5. By Application
    • 10.3.3. UAE In-Vitro Fertilization Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Technique
        • 10.3.3.2.2. By Product
        • 10.3.3.2.3. By Egg Donor
        • 10.3.3.2.4. By Infertility
        • 10.3.3.2.5. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Global In-Vitro Fertilization Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. The Fertility Center of Las Vegas
    • 15.1.1. Business Overview
    • 15.1.2. Company Snapshot
    • 15.1.3. Products & Services
    • 15.1.4. Financials (As Reported)
    • 15.1.5. Recent Developments
    • 15.1.6. Key Personnel Details
    • 15.1.7. SWOT Analysis
  • 15.2. Overlake Reproductive Health
  • 15.3. Gennet City Fertility
  • 15.4. Zita West Clinic
  • 15.5. Fertility Plus Clinic
  • 15.6. Nova IVF Centre and Fertility Clinic
  • 15.7. Bloom IVF Centre
  • 15.8. Progenesis Fertility Center
  • 15.9. Medicana IVF Center
  • 15.10. Medical Park Hospitals
  • 15.11. ART Fertility Clinics

16. Strategic Recommendations

17. About Us & Disclaimer